View of ANTI-AMYLOID MONOCLONAL ANTIBODIES IN EARLY ALZHEIMER'S DISEASE: BENEFITS AND SAFETY SIGNALS

Return to Article Details ANTI-AMYLOID MONOCLONAL ANTIBODIES IN EARLY ALZHEIMER'S DISEASE: BENEFITS AND SAFETY SIGNALS Download Download PDF